BIOTECHNOLOGY

Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical

GV101, is a novel, highly selective ROCK2 inhibitor, yielded an [...]

By |2026-08-26T15:04:44+00:00August 26, 2026|3rd Party Medical Device Industry News|Comments Off on Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical

Vector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products

This collaboration is a strong strategic and financial fit for [...]

By |2026-07-28T12:03:39+00:00July 28, 2026|3rd Party Medical Device Industry News|Comments Off on Vector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products

Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection (PJI) Under an Expanded Access Chronic Care Management Protocol

Lysins are a promising new family of enzyme-based antimicrobials which [...]

By |2026-07-10T15:14:25+00:00July 10, 2026|3rd Party Medical Device Industry News|Comments Off on Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection (PJI) Under an Expanded Access Chronic Care Management Protocol
Go to Top